Menu
Back to Journals » Cancer Management and Research » Volume 8 » default
Cancer Management and Research
ISSN: 1179-1322
- View all (4632)
- Volume 16, 2024 (38)
- Volume 15, 2023 (153)
- Volume 14, 2022 (330)
- Volume 13, 2021 (890)
- Volume 12, 2020 (1256)
- Volume 11, 2019 (969)
- Volume 10, 2018 (645)
- Volume 9, 2017 (89)
- Volume 8, 2016 (17)
- Volume 7, 2015 (33)
- Volume 6, 2014 (43)
- Volume 5, 2013 (41)
- Volume 4, 2012 (47)
- Volume 3, 2011 (32)
- Volume 2, 2010 (32)
- Volume 1, 2009 (17)
Archive: Volume 8, 2016
Implantation of permanent pleural catheter for palliation of malignant pleural effusion
Meier M, Mortensen MR, Larsen LU
Cancer Management and Research 2016, 8:129-133
Published Date: 8 November 2016
Treatment challenges for community oncologists treating postmenopausal women with endocrine-resistant, hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer
Abdel-Razeq H
Cancer Management and Research 2016, 8:127-128
Published Date: 20 October 2016
Atypical teratoid/rhabdoid tumors: challenges and search for solutions
Biswas A, Kashyap L, Kakkar A, Sarkar C, Julka PK
Cancer Management and Research 2016, 8:115-125
Published Date: 16 September 2016
Role of tolvaptan in the management of hyponatremia in patients with lung and other cancers: current data and future perspectives
Thajudeen B, Salahudeen AK
Cancer Management and Research 2016, 8:105-114
Published Date: 22 August 2016
Advanced soft-tissue sarcoma and treatment options: critical appraisal of trabectedin
Desar IME, Constantinidou A, Kaal SEJ, Jones RL, van der Graaf WTA
Cancer Management and Research 2016, 8:95-104
Published Date: 17 August 2016
Treatment challenges for community oncologists treating postmenopausal women with endocrine-resistant, hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer
Gradishar WJ
Cancer Management and Research 2016, 8:85-94
Published Date: 11 July 2016
Reappraisal of the role of dolasetron in prevention and treatment of nausea and vomiting associated with surgery or chemotherapy [Erratum]
Roberts SM, Bezinover DS, Janicki PK
Cancer Management and Research 2016, 8:83-84
Published Date: 28 June 2016
Fosaprepitant dimeglumine for the management of chemotherapy-induced nausea and vomiting: patient selection and perspectives
Candelario N, Lu MLR
Cancer Management and Research 2016, 8:77-82
Published Date: 22 June 2016
Treatment patterns, health state, and health care resource utilization of patients with radioactive iodine refractory differentiated thyroid cancer
Gianoukakis AG, Flores NM, Pelletier CL, Forsythe A, Wolfe GR, Taylor MH
Cancer Management and Research 2016, 8:67-76
Published Date: 30 May 2016
Novel approaches to target HER2-positive breast cancer: trastuzumab emtansine
Recondo G Jr, de la Vega M, Galanternik F, Díaz-Cantón E, Leone BA, Leone JP
Cancer Management and Research 2016, 8:57-65
Published Date: 19 May 2016
Dronabinol for chemotherapy-induced nausea and vomiting unresponsive to antiemetics
May MB, Glode AE
Cancer Management and Research 2016, 8:49-55
Published Date: 12 May 2016
Discoveries and application of prostate-specific antigen, and some proposals to optimize prostate cancer screening
Tokudome S, Ando R, Koda Y
Cancer Management and Research 2016, 8:45-47
Published Date: 10 May 2016
Multidisciplinary management for esophageal and gastric cancer
Boniface MM, Wani SB, Schefter TE, Koo PJ, Meguid C, Leong S, Kaplan JB, Wingrove LJ, McCarter MD
Cancer Management and Research 2016, 8:39-44
Published Date: 22 April 2016
Proactive management strategies for potential gastrointestinal adverse reactions with ceritinib in patients with advanced ALK-positive non-small-cell lung cancer
Schaefer ES, Baik C
Cancer Management and Research 2016, 8:33-38
Published Date: 24 March 2016
Neoadjuvant therapy for early-stage breast cancer: the clinical utility of pertuzumab
Gollamudi J, Parvani JG, Schiemann WP, Vinayak S
Cancer Management and Research 2016, 8:21-31
Published Date: 18 February 2016
EGFR testing and clinical management of advanced NSCLC: a Galician Lung Cancer Group study (GGCP 048-10)
Vázquez S, Casal J, Afonso Afonso FJ, Fírvida JL, Santomé L, Barón F, Lázaro M, Pena C, Amenedo M, Abdulkader I, González-Arenas C, Fachal L, Vega A
Cancer Management and Research 2016, 8:11-20
Published Date: 4 February 2016
Hemoglobin levels and quality of life in patients with symptomatic chemotherapy-induced anemia: the eAQUA study
Mouysset JL, Freier B, van den Bosch J, Levaché CB, Bols A, Tessen HW, Belton L, Bohac GC, Terwey JH, Tonini G
Cancer Management and Research 2016, 8:1-10
Published Date: 21 January 2016